FDA Inspection 904757 — Alfredo Gazca Aguilar, MD
The FDA completed an inspection of Alfredo Gazca Aguilar, MD on November 21, 2014 in Zapopan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 21, 2014
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Zapopan (Mexico)
Additional Details
Clinical Investigator (CI)